Form D · Pharmaceuticals
Eos SENOLYTIX, Inc.
Houston, TX · CIK 0002129803
Offering snapshot reported Aug 27, 2026 · SEC filing
- Reported sold
- $750K Offering amount: $25M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Jun 4, 2026 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 27, 2026 | Amendment | $750,000 | $0vs Jun 12, 2026 | 2 | SEC filing |
| Jun 12, 2026 | Initial | $750,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $1.42M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-587227
Sales Commissions are based on current estimates of the maximum amount of commission that may be paid. Additional platform/setup/verification fees apply and actual numbers may vary.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Floww Private Markets US Inc. | 000328174 | |
| Martijn de Wever | 007808596 | Floww Private Markets US Inc. · CRD 000328174 |
| Dov Kalton | 007213240 | Floww Private Markets US Inc. · CRD 000328174 |
Source: Form D, filed Aug 27, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frank Bartlett Mc Guyer | Director |
| Kevin Mark Slawin | Director, Executive |
| Jerold Winograd | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:Houston, TX, 77051
Phone: 3058096920